Day: December 2, 2020

With the proclamation of the success of the Pfizer and Moderna vaccines come the flurry of developers seeking emergency use approvals. In this article written by David Cyranoski for Nature, he discusses some of the concerns voiced out by various scientists: once the vaccines are approved for emergency use, they may compromise the ongoing trials…

In this November 23, 2020 article from CNN, members of the US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) say that Americans will need to be prepared for the possibility of side effects after getting the coronavirus vaccine. Experts say that vaccine providers must be ready to explain to…

In this article for the World Economic Forum, Katherine Ellen Foley reports on the top countries that have pre-ordered vaccines. According to Foley’s report, the most preferred vaccines are that of Pfizer, Moderna, and the AstraZeneca-Oxford. As of writing, the European Union, US, India, Japan, and the UK have collectively reserved over 2 billion doses.…

This article published by Nature last November 23, 2020 raises concerns about the results of the clinical trials of the vaccine jointly developed by the University of Oxford and pharmaceutical AstraZeneca. Overall efficacy of the vaccine is reported at 70% effective, but scientists are seeing that there is a striking difference in the efficacy of…

The following article was written by Mauro Gia Samonte for The Manila Times and was published December 1, 2020. In this article, Samonte reminds us of the Philippines’ experience with Dengvaxia, a vaccine for Dengue developed by Sanofi for 20 years, tested on 30,000 children for 9 years, and said to be safe. After inoculating…